新型冠狀病毒

Pfizer/BioNTech vaccine starts working 10 days after first dose, says FDA

Analysis comes ahead of meeting to debate whether vaccine should receive emergency approval in US

Pfizer and BioNTech’s Covid-19 vaccine starts to work within about 10 days of the first dose, according to new documents released by the US regulator ahead of an advisory meeting this week to discuss whether to grant it emergency approval.

Data released by the US Food and Drug Administration on Tuesday confirmed the vaccine had an efficacy rate of 95 per cent on average, with 93.8 per cent in participants over 55. It also showed Covid-19 cases began to taper off among those who had been vaccinated after just over a week, raising hopes that the inoculation could help ease pressures on overwhelmed hospitals soon after it is rolled out.

The data was released two days before a committee of scientific experts review the case for authorising the vaccine and make a recommendation to the FDA.

您已閱讀19%(793字),剩餘81%(3315字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×